Related Experiment Video
Updated: Jul 12, 2025

Author Spotlight: Understanding and Detecting Environmental Antimicrobial Resistance by Combining Culture-Based Techniques and Genomics
Published on: July 19, 2024
The global burden of antimicrobial resistance - urinary tract infections
Sibylle Von Vietinghoff1, Olga Shevchuk2, Ulrich Dobrindt3
1University Hospital Bonn, Medical Clinic 1, Section for Nephrology and University Bonn, Germany.
Abstract:
Antimicrobial resistance (AMR) has emerged as a significant global healthcare problem. Antibiotic use has accelerated the physiologic process of AMR, particularly in Gram-negative pathogens. Urinary tract infections (UTIs) are predominantly of a Gram-negative nature. Uropathogens are evolutionarily highly adapted and selected strains with specific virulence factors, suggesting common mechanisms in how bacterial cells acquire virulence and AMR factors. The simultaneous increase in resistance and virulence is a complex and context-dependent phenomenon. Among known AMR mechanisms, the plenitude of different β-lactamases is especially prominent. The risk for AMR in UTIs varies in different patient populations. A history of antibiotic consumption and the physiology of urinary flow are major factors that shape AMR prevalence. The urinary tract is in close crosstalk with the microbiome of other compartments, including the gut and genital tracts. In addition, pharmacokinetic properties and the physiochemical composition of urinary compartments can contribute to the emergence of AMR. Alternatives to antibiotic treatment and a broader approach to address bacterial infections are needed. Among the various alternatives studied, antimicrobial peptides and bacteriophage treatment appear to be highly promising approaches. We herein summarize the present knowledge of clinical and microbiological AMR in UTIs and discuss innovative approaches, namely new risk prediction tools and the use of non-antibiotic approaches to defend against uropathogenic microbes.
Insights
Antimicrobial resistance (AMR) is a growing threat, especially in urinary tract infections (UTIs) caused by Gram-negative bacteria. New strategies, including antimicrobial peptides and bacteriophages, are needed to combat resistant uropathogens.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Antimicrobial resistance (AMR) is a critical global health issue, accelerated by antibiotic use, particularly in Gram-negative pathogens.
- Urinary tract infections (UTIs) are frequently caused by Gram-negative bacteria, which exhibit high adaptation and possess specific virulence and AMR factors.
- The interplay between resistance and virulence in uropathogens is complex, with beta-lactamases being a prominent AMR mechanism.
Purpose of the Study:
- To summarize current knowledge on clinical and microbiological AMR in UTIs.
- To discuss the factors influencing AMR prevalence in UTIs, including antibiotic consumption and urinary tract physiology.
- To explore innovative, non-antibiotic approaches for combating uropathogenic microbes.
Main Methods:
- Review of existing literature on antimicrobial resistance in UTIs.
- Analysis of factors contributing to AMR emergence, such as antibiotic history and host-pathogen interactions.
- Evaluation of alternative treatments like antimicrobial peptides and bacteriophages.
Main Results:
- AMR in UTIs is influenced by patient populations, antibiotic history, and urinary tract conditions.
- Uropathogens demonstrate complex mechanisms for acquiring both virulence and AMR.
- Antimicrobial peptides and bacteriophage therapy show promise as alternatives to antibiotics.
Conclusions:
- Addressing AMR in UTIs requires a multifaceted approach beyond traditional antibiotics.
- Innovative strategies, including risk prediction and non-antibiotic therapies, are essential for future management of UTIs.
- Further research into antimicrobial peptides and bacteriophages is warranted for effective treatment of resistant uropathogen infections.
More Related Videos
Related Concept Videos
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urine Studies II: Urine Culture and Sensitivity Test
Urinary Tract Infection I: Introduction
Development of Antibiotic Resistance
Urinary Tract Infection IV: Nursing Management

